COVID-19

Advisory on measures to control COVID-19 following lifting of COVID-19 regulations

As of 22 June 2022, numbers of SARS-CoV-2 infections continue to decrease in South Africa, following the recent resurgence associated with the emergence of the Omicron BA.4 and BA.5 subvariants in South Africa. While numbers of cases and percentage testing positive did increase in this resurgence, the decoupling of numbers of hospitalisations and deaths from […]

Advisory on measures to control COVID-19 following lifting of COVID-19 regulations Read More »

COVID-19 Vaccine Booster Shot: Frequently Asked Questions

1. Why should I get vaccinated if the vaccine already needs a booster shot to protect me? Are vaccines not effective? Vaccines have been shown in controlled trials and in the evaluation of national vaccination programmes (e.g. United Kingdom) to reduce severe disease and mortality by up to 95-97%. This lifesaving effect has continued, even

COVID-19 Vaccine Booster Shot: Frequently Asked Questions Read More »

Changes to COVID-19 quarantine, isolation and contact tracing (17 Feb 2022)

As the COVID-19 pandemic evolves, new knowledge regarding the nature of COVID-19 infection, greater appreciation of the costs associated with current practices, as well as rising vaccination rates and immunity to COVID-19 infection amongst South Africans, have necessitated substantial revision of recommendations regarding quarantine, isolation and contract tracing. Isolation for Asymptomatic COVID infection People with

Changes to COVID-19 quarantine, isolation and contact tracing (17 Feb 2022) Read More »

Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa

Since the introduction of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in March 2020, South Africa has experienced three epidemic waves with the Beta and Delta variants of concern (VOCs) dominating the second and third waves, respectively. On 24 November 2021, the Network for Genomics Surveillance of South Africa (NGS-SA) reported a new variant of SARS-CoV-2

Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa Read More »

Limit the risk of COVID-19 transmission by avoiding super spreader events

The National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, continues to monitor developments around the newly emerged Omicron variant. “The number of new COVID-19 cases and the percent positivity continue to increase, likely due to spread of the Omicron variant. At this stage, scientists are trying to establish if

Limit the risk of COVID-19 transmission by avoiding super spreader events Read More »

Frequently asked questions for the B.1.1.529 mutated SARS-CoV-2 lineage in South Africa

The Network for Genomics Surveillance in South Africa (NGS-SA, www.ngs-sa.org), which includes the National Institute for Communicable Diseases (NICD), KRISP at the University of KwaZulu-Natal (UKZN), University of Cape Town (UCT), Stellenbosch University (SUN), the University of the Free State (UFS), the University of Pretoria, the University of the Witwatersrand (WITS) and the National Health

Frequently asked questions for the B.1.1.529 mutated SARS-CoV-2 lineage in South Africa Read More »

New COVID-19 variant detected in South Africa

The National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, confirms that through collaborative efforts with private laboratories and the NGS-SA members, a new COVID-19 variant, B.1.1.529, has been detected in South Africa. Twenty-two positive cases of variant B.1.1.529 have been recorded in the country following genomic sequencing collaborations between

New COVID-19 variant detected in South Africa Read More »

Scroll to Top